Financial insights of SPTX

MyFinsight

For the quarter ending 2026-03-31.

Income Statement	2026-03-31
Research and development (including stock-based compensation expense of 0.9 million and 0.5 million for three months ended march 31, 2026 and 2025, respectively)	21,431
General and administrative (including stock-based compensation expense of 1.7 million and 1.1 million for the three months ended march 31, 2026 and 2025, respectively)	6,112
Total operating expenses	27,543
Loss from operations	-27,543
Interest income, net	2,133
Research and development tax credit	567
Other expense, net	46
Total other income, net	2,654
Loss before income taxes	-24,889
Income tax provision	519
Net loss	-25,408
Foreign currency translation adjustment	15
Unrealized (loss) gain on available-for-sale securities	-252
Comprehensive loss	-25,645

Basic EPS	-10.34
Diluted EPS	-10.34
Basic Average Shares	2,456,766
Diluted Average Shares	2,456,766

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.